A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
Status:
Completed
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The study will look at how two different versions of semaglutide reach and stay in the blood
after injection. The study aims to show similar levels of semaglutide in the blood when using
the different versions. Participants will get both versions of semaglutide. The order in
which participants receive the versions is decided by chance. Participants will get the
medicines as an injection under the skin of the belly with the use of a pen-injector. The
study will last for about 11 to 17 weeks. Participants will have 27 visits with the study
doctor. At 2 visits, participants will stay in the clinic for 4 days and 3 nights.
Participants may have to stop the study if the study doctor thinks that there are risks for
their health. Women cannot take part if pregnant, breast-feeding or planning to become
pregnant during the study period.